Literature DB >> 10751212

Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.

S J Shankland1, G Wolf.   

Abstract

The response to glomerular and tubulointerstitial cell injury in most forms of renal disease includes changes in cell number (proliferation and apoptosis) and cell size (hypertrophy). These events typically precede and may be responsible for the accumulation of extracellular matrix proteins that leads to a decrease in renal function. There is increasing evidence showing that positive (cyclins and cyclin-dependent kinases) and negative (cyclin-dependent kinase inhibitors) cell cycle regulatory proteins have a critical role in regulating these fundamental cellular responses to immune and nonimmune forms of injury. Data now show that altering specific cell cycle proteins affects renal cell proliferation and improves renal function. Equally exciting is the expanding body of literature showing novel biological roles for cell cycle proteins in the regulation of cell hypertrophy and apoptosis. With increasing understanding of the role for cell cycle regulatory proteins in renal disease comes the hope for potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751212     DOI: 10.1152/ajprenal.2000.278.4.F515

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  34 in total

Review 1.  Chloride channels go cell cycling.

Authors:  B Nilius
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

2.  Overexpression of p18INK⁴C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis.

Authors:  Yi Zhang; Li Yuan; Lili Fu; Chunyan Liu; Dongmei Liu; Changlin Mei
Journal:  Pediatr Nephrol       Date:  2011-04-15       Impact factor: 3.714

3.  Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cells.

Authors:  Rong Tao; Chu-Pak Lau; Hung-Fat Tse; Gui-Rong Li
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

4.  Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.

Authors:  Jihua Tian; Yanhong Wang; Xinyan Liu; Xiaoshuang Zhou; Rongshan Li
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-27

Review 5.  Cell biology and pathology of podocytes.

Authors:  Anna Greka; Peter Mundel
Journal:  Annu Rev Physiol       Date:  2011-11-04       Impact factor: 19.318

6.  Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

Authors:  M Chiara; E Menegatti; D Di Simone; A Davit; D Bellis; D Sferch; G De Rosa; O Giachino; L M Sena; D Roccatello
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

7.  Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo.

Authors:  Haibo Yang; Peihao Yin; Zhan Shi; Yanchun Ma; Chenggen Zhao; Jampu Zheng; Teng Chen
Journal:  Oncol Lett       Date:  2015-10-29       Impact factor: 2.967

Review 8.  Therapeutic targets in focal and segmental glomerulosclerosis.

Authors:  Peter J Lavin; Rasheed Gbadegesin; Tirupapuliyur V Damodaran; Michelle P Winn
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

9.  Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats.

Authors:  Kumiko Nishihara; Satohiro Masuda; Shunsaku Nakagawa; Atsushi Yonezawa; Takaharu Ichimura; Joseph V Bonventre; Ken-ichi Inui
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-13

Review 10.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.